BNGOBionano Genomics, Inc.同业对比
Bionano Genomics, Inc. 与SIC 3826 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BNGO本股 | $13M#9 | — | 0.4x#3 | 0.5x#2 | -7.4%#7 | 76.4%#2 | -116.9%#5 | -83.5%#8 | — | — | -34.1%#6 | — |
| CTKB | $704M#1 | — | 2.2x#6 | 3.5x#7 | 0.5%#5 | -1005.3%#10 | -20.0%#2 | -20.7%#3 | — | — | 34.2%#3 | — |
| NAUT | $272M#2 | — | 2.3x#7 | — | — | 16.6%#4 | — | -50.6%#6 | — | — | 40.9%#2 | — |
| LAB | $247M#3 | 1.8x#2 | 0.4x#4 | 2.9x#6 | -6.2%#6 | 46.1%#3 | -129.2%#6 | -13.5%#2 | — | 5#2 | -44.7%#7 | — |
| QTRX | $130M#4 | — | 0.5x#5 | 0.9x#3 | 1.1%#4 | -178.4%#8 | -90.4%#4 | -45.2%#5 | -63.7%#2 | 3#3 | -46.7%#8 | — |
| SEER | $90M#5 | — | 0.4x#2 | 5.4x#8 | 17.0%#2 | 15.0%#5 | -470.5%#8 | -32.6%#4 | — | — | -25.7%#5 | — |
| HBIO | $38M#6 | 0.9x#1 | 5.2x#9 | 0.4x#1 | -8.1%#8 | -357.1%#9 | -56.1%#3 | -764.4%#10 | -129.2%#3 | — | 44.3%#1 | — |
| PRPO | $34M#7 | — | 2.4x#8 | 1.4x#5 | 30.5%#1 | 91.5%#1 | -5.0%#1 | -2.5%#1 | -10.4%#1 | 6#1 | -10.6%#4 | — |
| EYPT | $30M#8 | — | 0.2x#1 | 1.0x#4 | -27.5%#9 | -77.2%#6 | -776.0%#9 | -139.4%#9 | — | — | -96.8%#9 | — |
| BFNH | — | — | — | — | 9.0%#3 | -163.4%#7 | -261.8%#7 | -56.1%#7 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-06。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议